ArticleNano-micro letters2026
Ultramicropore-Confined Solvation and Interphase Regulation Unlock High-Performance Hard Carbon Anodes for Sodium-Ion Batteries.
Article in Nano-micro letters, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hard carbon (HC) anodes are promising for sodium-ion batteries, yet achieving high initial Coulombic efficiency (ICE), large plateau contribution, and fast charge-transfer kinetics remains challenging due to insufficient control of micro-nanostructure and interphase chemistry. Here, we present a precursor-level molecular engineering strategy that simultaneously regulates sodium desolvation and interphase chemistry in HC. An iodine-mediated oxidative cross-linking process converts starch into spherical HC with uniformly distributed ultramicropores and carbonyl-rich surfaces. These nanoconfined pores are proposed to act as molecular sieves, preferentially excluding bulky solvent molecules while allowing PF
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.